ExosensLSE:0EXO 46 ROE % is 1.28% as of Dec. 2025, which is 81% below its 10-year median of 6.73. GuruFocus rates LSE:0EXO with a GF Score™ of 46/100. The stock has 3 warning signs investors should review. Among 3,004 Industrial Products companies, Exosens ranks better than 55.76% on this metric.
ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Exosens's annualized net income for the quarter that ended in Dec. 2025 was €5.6 Mil. Exosens's average Total Stockholders Equity over the quarter that ended in Dec. 2025 was €437.6 Mil. Therefore, Exosens's annualized ROE % for the quarter that ended in Dec. 2025 was 1.28%.
The historical rank and industry rank for Exosens's ROE % or its related term are showing as below:
LSE:0EXO'
s ROE % Range Over the Past 10 Years
Min: -110.67 Med: 6.73 Max: 13.85
Current: 7.15
During the past 6 years, Exosens's highest ROE % was 13.85%. The lowest was -110.67%. And the median was 6.73%.
LSE:0EXO's ROE % is ranked better than 55.76% of 3004
companies
in the Industrial Products industry
Industry Median: 5.865
vs LSE:0EXO: 7.15
Exosens (LSE:0EXO) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Exosens ROE % Related Terms
Exosens ROE % Historical Data
* Premium members only.
The historical data trend for Exosens's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Electrical Equipment & Parts subindustry, Exosens's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Exosens ROE % vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Exosens's ROE % distribution charts can be found below:
* The bar in red indicates where Exosens's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
ROE % is displayed in the 30-year financial page.
Exosens (LSE:0EXO) has a ROE % of 1.28% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Exosens and its competitors. This is 81% below median its historical median of 6.73. According to the industry distribution chart, Exosens ranks #1329 out of 3004 companies in the Industrial Products industry, placing it in the top 44.2%.
Is Exosens' ROE % too high?
Exosens' current ROE % of 1.28% is 81% below median its 10-year median of 6.73. The Industrial Products industry median ROE % is 5.87. Exosens' value of 1.28% is 78.2% below this industry median. Based on the distribution chart, Exosens ranks #1329 out of 3004 companies in the Industrial Products industry, which is above the industry midpoint. Overall, Exosens has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.
How does Exosens' ROE % compare to VRT and BE?
According to the Industrial Products industry distribution chart, Exosens ranks #1329 out of 3004 companies for ROE %. This puts Exosens in the upper half of its industry. The industry median ROE % is 5.87. Exosens' value of 1.28% is 78.2% below this benchmark. While the company's 10-year median is 6.73 vs. the industry median of 5.87, Exosens has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for an Industrial Products company?
The median ROE % among Industrial Products companies is 5.87, based on 3,004 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Exosens's current ROE % of 1.28% is 78.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Exosens and its competitors. For the Industrial Products industry, the median ROE % is 5.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Exosens's current ROE % is 1.28%, which is 81% below median its own 10-year median of 6.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Exosens stock overvalued right now?
Exosens (LSE:0EXO) has a current ROE % of 1.28%. The current ROE % is 1.28%, which is 81% below median its 10-year median of 6.73 and 78.2% below the Industrial Products industry median of 5.87. Exosens' overall GF Score™ is 46/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Exosens (LSE:0EXO), the current ROE % is 1.28% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Exosens SA is a high-tech company specializing in electro-optical technologies for amplification, detection, and imaging. It offers products such as night vision tubes, ultraviolet cameras, travelling wave tubes, and various detectors for defense, life sciences, nuclear, and industrial sectors. With multiple production sites in Europe and North America. The company's activities are organized into two main segments: Amplification, which focuses on electron or electromagnetic wave amplification systems mainly used in defense night vision equipment and generates the majority of its revenue, and Detection & Imaging, which provides high value-added components for commercial markets such as nuclear power, research, and industrial applications.
46GF Score
Get the complete analysis for LSE:0EXO
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:0EXO has been successfully added to your 
